Business Wire

Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

LEXINGTON, Mass. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alloy Therapeutics (“Alloy”) and Pyxis Oncology ("Pyxis") today announced the formation of a joint venture named Kyma Therapeutics to develop ...
Shanghai Metals Market

Dual Giants Secure Nearly 100 Orders, Semi-Solid Magnesium Alloy Forming Equipment Sees Application Boom [SMM Domestic Analysis]

Two Giants Secure Nearly 100 Orders, Semi-Solid Magnesium Alloy Forming Equipment Sees Application Boom] Recently, the field of semi-solid magnesium alloy forming equipment has witnessed significant ...
Business Wire

Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases

SOUTH SAN FRANCISCO, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--Maze Therapeutics, a company focused on translating genetic insights into new medicines, and Alloy Therapeutics, a company developing ...
GEN

Alloy and Wheeler Bio Form Nonexclusive Preferred Service Offering

Alloy Therapeutics and CDMO Wheeler Bio formed a nonexclusive, preferred service offering to advance potential new products from discovery to CMC development, GMP manufacturing, and clinical material ...